GeneFerm Biotechnology Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 88.729 million compared to TWD 72.587 million a year ago. Operating loss was TWD 5.053 million compared to TWD 4.276 million a year ago. Net loss was TWD 5.695 million compared to TWD 4.804 million a year ago. Basic loss per share was TWD 0.2 compared to TWD 0.17 a year ago.